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Abstract 
Objectives: The relationship between polymorphic 
variants of folate metabolism genes with clinical 
(blood pressure level before and at the end of 
pregnancy) and clinical and laboratory indicators 
(proteinuria, fibrinogen, total protein, urea and 
creatinine in the blood, activated partial 
thromboplastin time, thrombin time) were studied in 
pregnant women with preeclampsia. Materials and 
Methods: The study group included 322 pregnant 
women diagnosed with preeclampsia and 179 
women with normal pregnancy. Polymorphisms of 
the folate cycle genes (MТHFR +677С>Т 
(rs1801133), MТHFR +1298 A>С (rs1801131), 
MТRR +66 A>G (rs1801394), MТR +2756 A>G 
(rs1805087)) were studied by real-time polymerase 
chain reaction (PCR) of DNA synthesis (Real-time-
PCR). Results: Polymorphic markers +2756 AA 
MТR and +1298 AС, +1298СС MТHFR are 
associated with an increased level of diastolic and 
systolic blood pressure, respectively, in women with 
pre-eclampsia prior to pregnancy. The genotypes 
+677ST and + 677TT MTHFR are associated with 
an increased level of proteinuria, and the genetic 
variants of +2756 AA MTR and +66GG MTRR are 
associated with a lower protein content in the blood 
and a high proteinuria level in pregnant women with 
preeclampsia. Conclusions: Thus, as a result of this 
study, significant associations of genetic 
polymorphisms MТHFR +677С>Т, MТHFR +1298 
A>С, MТR +2756 A>G, MТRR +66 A>G with 
indices of blood pressure, protein content in the 
blood, proteinuria level in pregnant women with 
preeclampsia were determined. 
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Introduction 
Preeclampsia is a multisystem pathological 
condition that occurs in the second half of pregnancy 
(after the 20th week) characterized by hypertension 
in combination with proteinuria, often with edema 
and multiple organ dysfunction (Williams et al, 
2011, Sidorova, 2016). The frequency of PE is 8-
20% among all pregnant women (Suhih, Murashko, 
2010). During the last decade, preeclampsia is one of 
the main factors of perinatal morbidity in the world 
and stably ranks 3rd-4th in the structure of the causes 
of maternal morbidity and mortality (Ajlamazyan, 
Mozgovaya, 2010, Sidorova, 2016). 
Analysis of modern literature indicates that PE is a 
multifactorial disease. Genetic component of PE 
development can account for up to 50% of all risk 
factors (Baranov, 2009; Reshetnikov et al., 2017).  
An important role in the etiology and pathogenesis 
of preeclampsia belongs to the candidate genes for 
folate metabolism (Vorozhishcheva, 2014; Zhou et 
al., 2016). Mutations in the genes of folate 
metabolism, which lead to a decrease in the activity 
of methyltetrahydrofolate reductase enzymes and 
methionine synthase reductase, lead to an excessive 
accumulation of homocysteine in the blood and, as a 
result, disruption of methylation processes in cells 
(Vorozhishcheva, 2014). Deficiency of folic acid 
causes the formation of hypertension in pregnant 
women, the development of total angiopathy, 
microthrombosis, increased insulin resistance. It 
should be noted that the role of candidate genes for 
folate metabolism in the formation of PE has been 
actively studied, but these studies often give 
conflicting results in different populations of the 
world (Obolenska et al., 2011; Pavlova et al., 2011; 
Williams et al., 2011; Valenzuela et al., 2012; Reilly 
et al., 2014; Vorozhishcheva, 2014;).  
 
Materials and Methods 
Group characteristics 
According to the goals and objectives of the study, 
501 women were examined: 322 pregnant women 
diagnosed with preeclampsia and 179 women with 
normal pregnancy (control group). All clinical 
studies were carried out according to the protocols of 
the ethical committee of the Russian Federation, 
with the informed consent of the patients. The 
present study includes persons of Russian nationality 
not being of kin to each other, born in the Central 
Black Earth region of Russia. Clinical and laboratory 
examination of women of the main and control 
groups was performed at the time of delivery in the 
Perinatal Center of St. Joasaph Belgorod Regional 
Clinical Hospital.  
The main group included pregnant women 
diagnosed with preeclampsia. The diagnosis of 
preeclampsia was based on generalized edema, 
arterial hypertension and proteinuria (Sidorova, 
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2016). The average age of women with PE was 
27.19±6.4 years (ranging from 18 to 44 years). The 
control group included pregnant women without 
preeclampsia aged 19 to 41 years (mean age of 
women was 26.71±6.36 years) (p>0.05). Thus, the 
control group of pregnant women did not differ from 
the main group by sex, place of birth, age and 
nationality. 
Exclusion criteria for the formation of the sample 
were: the presence of uterine pathology (uterine 
fibroids, internal genital abnormalities) among 
patients, pathology of pregnancy (abnormal 
attachment and location of the placenta, rhesus-
conflict), fetal pathology (congenital 
malformations), and multiple pregnancy. 
Blood pressure (BP, mm Hg) in pregnant women 
was measured three times on both hands in a sitting 
position at intervals of one minute. The mean of the 
last two measurements were taken for the final BP. 
Data on the level of systolic and diastolic blood 
pressure in women before pregnancy were copied 
from their case records. 
All pregnant women underwent the necessary 
laboratory examination, including: complete blood 
count, coagulogram, blood chemistry, common urine 
analysis (protein, specific gravity, epithelium, 
leukocytes, cylinders), Nechiporenko urine analysis, 
and Zimnitskii urine analysis (leukocytes, 
erythrocytes). 
Molecular and Genetic Methods 
On the basis of the Human Molecular Genetics 
research laboratory of Belgorod State National 
Research University, all pregnant women with 
preeclampsia and the control group were typed their 
polymorphic variants of folate cycle genes: 
methylenetetrahydrofolate reductase (MТHFR 
+677С>Т (rs1801133), MТHFR +1298 A>С 
(rs1801131), methionine synthase reductase (MТRR 
+66 A>G (rs1801394)), and methionine synthase 
(MТR +2756 A>G (rs1805087)). The material for 
the study was venous blood obtained in the volume 
of 8-9 ml from the ulnar vein of the pregnant women. 
All polymorphic variants of folate cycle enzymes 
were analyzed with the use of real-time DNA 
polymerase chain reaction (PCR) (Real-time-PCR).  
Statistical Methods 
The formation of database and the statistical 
calculations were carried out using the 
“STATISTICA 6.0” program. Genetic and 
phenotypic frequencies were calculated by standard 
methods. The conformity of the observed 
distribution of genotypes to the expected one, based 
on the Hardy-Weinberg equilibrium, was performed 
using the χ2 criterion. In order to minimize the errors 
of the first kind (false positive results), the 
Bonferroni correction was used for multiple 
comparisons. 
Investigation of the relations of polymorphic 
variants with pathogenetically significant 
quantitative characteristics of PE (blood pressure 
level, fibrinogen level, prothrombin index, etc.) was 
carried out using nonparametric statistics (Rebrova, 
2006).  
 
Results 
As a result of the study, it was found that women 
with PE with genotype +2756 AA MTR have the 
level of diastolic blood pressure before the onset of 
pregnancy (Me=70.0 mmHg, Q25-Q75=70.0-80.0 
mmHg) statistically significantly higher than that of 
individuals with genotypes +2756AG and +2756GG 
at this locus (Me=70.0 mmHg, Q25-Q75=70.0-70.0 
mmHg, p=0.04). Pregnant women with PE with 
genotype +2756 AA MTR also have the level of the 
total protein in blood (Me=62.0 g/l, Q25-Q75=60.0-
67.0 g/l) lower as compared to individuals with 
genotypes +2756AG and +2756GG for this locus 
(Me=64.0 g/l, Q25-Q75=61.0-68.0 g/l, p=0.05).  
Women with PE with genotypes +1298AC and 
+1298SS MTHFR have the level of SBP before 
pregnancy (Me=110.0 mmHg, Q25-Q75=110.0-
120.0 mmHg) and proteinuria during pregnancy 
(Me=0.066 g/l., Q10-Q90=0.033-0.160 g/l) 
statistically significantly higher than those of 
individuals with genotype +1298AA MTHFR 
(Me=110.0 mmHg, Q25-Q75=110.0-115.0 mm Hg; 
p=0.03 and Me=0.066 g/l, Q10-Q90=0.033-0.099 
g/l; p=0.03, respectively).  
Individuals with genotype +66GG MTRR have a 
lower total protein level in the blood (Me=62.0 g/l, 
Q25-Q75=58.0-66.0 g/l.) compared with women 
with genotypes +66AG and +66AA MTRR (Me=63.0 
g/l, Q25-Q75=61.0-68.0 g/l; p=0.05). 
It was found that the level of proteinuria (Me=0.066 
g/l, Q10-Q90=0.033-0.125 g/l) in pregnant women 
with PE with genotypes +677ST and +677TT 
MTHFR is higher than in pregnant women with 
genotype +677SS MTHFR (Me=0.066 g/l, Q10-
Q90=0.033-0.120 g/l; p=0.04).   
 
Discussion 
As the results of the present study indicate, the 
polymorphisms of the folate metabolism genes 
(MТR +2756 A>G, MТHFR +1298 A>С, MТRR 
+66 A>G, MТHFR +677С>Т) have important 
pathogenetic significance in the formation of clinical 
and clinical laboratory parameters in pregnant 
women with PE. Polymorphic markers +2756 A A 
MТR and +1298 AС, +1298СС MТHFR are 
associated with an increased level of diastolic and 
systolic blood pressure, respectively, in women with 
pre-eclampsia prior to pregnancy. The genotypes 
+677ST and + 677TT MTHFR are associated with 
an increased level of proteinuria, and the genetic 
variants of +2756 AA MTR and +66GG MTRR are 
associated with a lower protein content in the blood 
and a high proteinuria level in individuals whose 
pregnancy had been complicated with preeclampsia. 
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The following medical and biological mechanisms 
can be based on the revealed links of genetic 
polymorphisms of folate cycle genes with clinical 
and clinical-laboratory parameters of women with 
PE. According to the published data, the individuals 
homozygous for allele +1298C MTHFR have a 
decrease in the activity of MTHHRR up to 60% of 
the norm (Friedman et al., 1999), and those 
homozygous for allele +677Т MTHFR have a 
decrease in the activity of the enzyme up to 30%, 
heterozygous for +677ST MTHFR - up to 65% 
(Bailey et al., 1999). Reduction in the activity of 
folate cycle enzymes (methylene tetrahydrofolate 
reductase, methionine synthase, methionine 
synthase reductase) (in individuals with genetic 
variants +677ТТ, +677СТ MТHFR, +1298СС 
MТHFR, +1298 AС) leads to disruption of the 
delivery and metabolism of folic acid, accumulation 
of homocysteine   in plasma and the development of 
hyperhomocysteinemia (Suhovol'skaya et al., 2012). 
At the same time, homocysteine   begins to show its 
toxic properties, which primarily affects the vascular 
walls. According to the literature, a high level of 
homocysteinemia (HC) is a risk factor for the 
development of both atherosclerotic and 
thrombogenic vascular lesions. An increase in the 
concentration of homocysteine   increases oxidative 
stress, stimulates the production of smooth muscle 
cells and alters the elastic properties of the vascular 
wall (Strizhakov et al., 2009). Microcirculation 
disorders increase permeability of blood vessels, 
which leads to deterioration of rheological properties 
of blood, slowing thereby blood flow in the 
microcirculatory bed, increasing peripheral 
resistance and, as a consequence, to hypertension, 
which in turn increases the risk of pre-eclampsia and 
the severity of its manifestations (proteinuria, 
hypoproteinemia) (Baranov, Bolshakova, 2004).  
Various studies on the search for associations of 
folate cycle genes with clinical and clinical-
laboratory indicators in pregnant women have 
obtained conflicting results. Thus, in the Portuguese 
population, the relation of genotype +677TT 
MTHHRR was established with a decrease in SBP 
and DBP in women with gestational hypertension 
(Matos et al., 2013), and the study of the Yakut, 
Buryat and Russian populations revealed no 
associations of polymorphism MТHFR +677С>Т 
with the level of blood pressure, proteinuria and 
hypoproteinemia in pregnant women with 
preeclampsia (Vorozhishcheva, 2014). A similar 
study of the Russian population of Central Russia 
also revealed no relations of the polymorphic marker 
of the MTHFR gene with proteinuria and arterial 
hypertension in pre-eclampsia (Halford-Knyazeva, 
2013). 
The discrepancy between the results obtained in 
various studies may be related to differences in the 
ethnic and, respectively, the genetic background of 
the populations under study. (Churnosov et al., 2005, 
Sorokina et al., 2007). 
Thus, as a result of this study, significant 
associations of folate metabolism genes with 
elevated blood pressure levels in women before 
pregnancy, increased proteinuria and a lower protein 
content in pregnant women with preeclampsia were 
established. 
 
Conclusion 
The data obtained as a result of the research broaden 
the understanding of the mechanisms of 
preeclampsia development, and also allows 
predicting the nature of the clinical course of the 
disease, which will ensure optimization of the 
treatment and diagnostic process for each patient. 
The polymorphisms MТR +2756 A>G, MТHFR 
+1298 A>С, MТHFR +677С>Т, MТRR +66 A>G 
can be used to predict blood pressure levels, 
proteinuria levels, and protein content in pregnant 
women with preeclampsia. 
 
MТHFR +677С>Т (rs1801133), MТHFR +1298 
A>С (rs1801131), MТRR +66 A>G (rs1801394), 
MТR +2756 A>G (rs1805087)) 
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